Boston Scientific says a probe by the U.S. District Attorney for Massachusetts into its cardiac rhythm management unit is over. A probe by the U.S. District Attorney for Massachusetts into Boston Scientific’s (NYSE:BSX) cardiac rhythm management unit has been put to bed, the medical device company said yesterday. The Bay State DA’s office sent a subpoena to Natick, Mass.-based Boston Scientific in March 2010, “relating to the former Market Development Sales Organization that operated within our CRM business,” according to a regulatory filing.
Help employers find you! Check out all the jobs and post your resume.
